Benitec Biopharma Inc. (BNTC)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20264 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Benitec Biopharma Inc.’s names, not what it holds today.
0 published
2 published
1 published
Names not counted (3)
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Mar 19, 2024 | 11,932,852 | Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof | Pharmaceuticals | Benitec IP Holdings Inc. |
| Dec 27, 2022 | 11,535,851 | Reagents for treatment of hepatitis B virus (HBV) infection and use thereof | Pharmaceuticals | Benitec IP Holdings Inc. |
| Nov 15, 2022 | 11,499,141 | Adeno-associated virus (AAV) with modified phospholipase domain | Biotechnology | Benitec IP Holdings Inc. |
| Oct 12, 2021 | 11,142,765 | Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof | Pharmaceuticals | Benitec IP Holdings Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Mar 31, 2022 | 2022/0098614 | Compositions and Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD) | Biotechnology | Benitec IP Holdings Inc. |
| Feb 24, 2022 | 2022/0056446 | Reagents for Treatment of Oculopharyngeal Muscular Dystrophy (OPMD) and Use Thereof | Pharmaceuticals | Benitec IP Holdings Inc. · patent 11,932,852 granted from it |
| Jul 16, 2015 | 2015/0197751 | RNAI EXPRESSION CONSTRUCTS | Biotechnology | BENITEC, INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.